Recombinant human erythropoietin increases cerebral cortical width index and neurogenesis following ischemic stroke

Neural Regeneration Research

Volumn 7, Issue 8, 2012, Pages 578-582

  Wen, Zhongmin ^a   Wang, Peiji ^b  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Cerebral infarction; Erythropoietin; Neural regeneration; Neurogenesis

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL NUCLEUS ANTIGEN; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CORTEX; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL EXPANSION; CELL HYPERPLASIA; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CONVALESCENCE; IMMUNOFLUORESCENCE TEST; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN;

EID: 84859168783     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2012.08.003     Document Type: Article

References (39)

1. Galldiks N, Zaro-Weber O, Dohmen C, et al. Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the Cologne Stroke Experience. Cerebrovasc Dis. 2010;30(5):514-518.
2. Machumpurath B, Davis SM, Yan B. Rapid neurological recovery after intravenous tissue plasminogen activator in stroke: prognostic factors and outcome. Cerebrovasc Dis. 2011;31(3): 278-283.
3. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38(5):1655-1711.
4. Martinez-Vila E, Sieira PI. Current status and perspectives of neuroprotection in ischemic stroke treatment. Cerebrovasc Dis. 2001;11(Suppl 1):60-70.
5. Danton GH, Dietrich WD. The search for neuroprotective strategies in stroke. AJNR Am J Neuroradiol. 2004;25(2):181-194.
6. Du Y, Shi L, Li J, et al. Angiogenesis and improved cerebral blood flow in the ischemic boundary area were detected after electroacupuncture treatment to rats with ischemic stroke. Neurol Res. 2011;33(1):101-107.
7. Miriam N, Anna R, Mar H, et al. A large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke. Atherosclerosis. 2011;216(1):205-211.
8. Maria K, Evgeny K, Oleg T, et al. Increased subventricular zone-derived cortical neurogenesis after ischemic lesion. Exp Neurol. 2010;226(1):90-99.
9. Ruifrok WP, de Boer RA, Iwakura A, et al. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia. Vasc Med. 2009;14(1):129-136.
10. Liu X, Li Y, Liu Y, et al. Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy. Am J Pathol. 2010;176(1):504-515.
11. Rosemeire M, Lauro M, Konstantinos H, et al. Effects of combination of proliferative agents and erythropoietin on left ventricular remodeling post-myocardial infarction. Clin Transl Sci. 2011;4(3):168-174.
12. Ehrenreich H, Weissenborn K, Prange H, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009;40(12):e647-656.
13. Minnerup H, Herdrich J, Rogalewski A, et al. The efficacy of erythropoietin and its analogues in animal model: a meta-analysis. Stroke. 2009;40(9):3113-3120.
14. Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ. 2004;11(Suppl 1): S37-44.
15. Shang Y, Yao SL, Wu Y. Erythropoietin protects neuron against ketamine induced injuries. Zhonghua Yi Xue Za Zhi. 2008;88(13): 876-879.
16. Dong WB, Hou HM, Wang Q, et al. NF-kappaB-mediated protective effect of erythropoitin on neuron against glutamate-induced damage. Xibao yu Fenzi Mianyixue Zazhi. 2008;24(6):584-585.
17. Osredkar D, Sall JW, Bickler PE, et al. Erythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke. Neurobiol Dis. 2010;38(2):259-265.
18. Xiong Y, Mahmood A, Meng Y, et al. Delayed administration of erythropoietin reducing hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome following traumatic brain injury in rats: comparison of treatment with single and triple dose. J Neurosurg. 2010;113(3): 598-608.
19. Wang L, Chopp M, Gregg SR, et al. Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF. J Cereb Blood Flow Metab. 2008;28(7):1361-1368.
20. Chang YS, Mu D, Wendland M, et al. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res. 2005;58(1):106-111.
21. Lu D, Mahmood A, Qu C, et al. Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma. 2005;22(9):1011-1017.
22. Gonzalez FF, Abel R, Almli CR, et al. Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Dev Neurosci. 2009;31(5):403-411.
23. Ma DK, Bonaguidi MA, Ming GL, et al. Adult neural stem cells in the mammalian central nervous system. Cell Res. 2009; 19(6): 672-682.
24. Bacigaluppi M, Pluchino S, Martino G, et al. Neural stem/precursor cells for the treatment of ischemic stroke. J Neurol Sci. 2008;265(1-2):73-77.
25. Hagg T. From neurotransmitters to neurotrophic factors to neurogenesis. Neuroscientist. 2009;15(1):20-27.
26. Fletcher L, Kohli S, Sprague SM, et al. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation. J Neurosurg. 2009;111(1):164-170.
27. Heeschen C, Aicher A, Lehmann R, et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 2003;102(4):1340-1346.
28. Takahashi T, Kalka C, Masuda H, et al. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5(4): 434-438.
29. Iwaguro H, Yamaguchi J, Kalka C, et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation. 2002;105(6):732-738.
30. Liu X, Li Y, Liu Y, et al. Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy. Am J Pathol. 2010;176(1):504-515.
31. Krenning G, van Luyn MJ, Harmsen MC. Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med. 2009;15(4):180-189.
32. Westenbrink BD, Lipsic E, van der Meer P, et al. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J. 2007;28(16):2018-2027.
33. Villa P, Bigini P, Mennini T, et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med. 2003; 198(6):971-975.
34. Warren JS, Zhao Y, Yung R, et al. Recombinant human erythropoietin suppresses endothelial cell apoptosis and reduces the ratio of Bax to Bcl-2 proteins in the aortas of apolipoprotein E-deficient mice. J Cardiovasc Pharmacol. 2011;57(4):424-433.
35. Shi X, Kang Y, Hu Q, et al. A long-term observation of olfactory ensheathing cells transplantation to repair white matter and functional recovery in a focal ischemia model in rat. Brain Res. 2010;1317:257-267.
36. He JS, Huang ZL, Yang H, et al. Early use of recombinant human erythropoietin promotes neurobehavioral development in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi. 2008;10(5):586-588.
37. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
38. Taguchi A, Wen Z, Myojin K, et al. Granulocyte colony-stimulating factor has negative effect on stroke outcome in a murine model. Eur J Neurosci. 2007;26(1):126-133.
39. Taguchi A, Kasahara Y, Nakagomi T, et al. A reproducible and simple model of permanent cerebral ischemia in CB-17 and SCID Mice. J Exp Stroke Transl Med. 2010;3(1):28-33.